Activated Protein C in Acute Stroke Trial "APCAST"

Terminated

Phase 2 Results N/A

Summary of Purpose

The purpose of this research study is to determine the safety and learn more about the dose of Activated Protein C (APC) in reducing the damage from stroke. Trial Stopped: Lack of recruitment

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 10 December 2010.

1 Sep 2007 19 Sep 2007 1 Oct 2010 1 Dec 2010 1 Dec 2010 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors

Trial Design

  • Allocation: Non-Randomized
  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Single Group Assignment

Contacts

Not available